Cargando…

Anti-cytotoxic T lymphocyte antigen-4 antibodies in melanoma

Approaches aimed at enhancement of the tumor specific response have provided proof for the rationale of immunotherapy in cancer, both in animal models and in humans. Ipilimumab, an anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) antibody, is a new generation immunotherapeutic agent that has shown act...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tosti, Giulio, Cocorocchio, Emilia, Pennacchioli, Elisabetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804494/ https://www.ncbi.nlm.nih.gov/pubmed/24204168 http://dx.doi.org/10.2147/CCID.S24246

Ejemplares similares

The monoclonal antibody to cytotoxic T lymphocyte antigen 4, ipilimumab, in the treatment of melanoma
por: Verschraegen, Claire
Publicado: (2012)

Sunny Holidays before and after Melanoma Diagnosis Are Respectively Associated with Lower Breslow Thickness and Lower Relapse Rates in Italy
por: Gandini, Sara, et al.
Publicado: (2013)

Proceedings: Lymphocyte dependent cytotoxic antibody activity against human melanoma antigens.
por: Vanwijck, R., et al.
Publicado: (1974)

Novel Biomarkers and Druggable Targets in Advanced Melanoma
por: Ferrucci, Pier Francesco, et al.
Publicado: (2021)

Dabrafenib in metastatic melanoma: a monocentric ‘real life’ experience
por: Cocorocchio, E, et al.
Publicado: (2016)

Vulvar vitiligo-like depigmentation and multiple halos of hypomelanosis at the trunk following treatment with imiquimod 5% cream for vulvar condylomata: casual or related events?
por: Serra, Maíra Chiarelli, et al.
Publicado: (2014)

Dose escalation phase 1 study of radiotherapy in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 monoclonal antibody ipilimumab in patients with metastatic melanoma
por: Boutros, Celine, et al.
Publicado: (2020)

The Role of Photodynamic Therapy in the Treatment of Vulvar Intraepithelial Neoplasia
por: Tosti, Giulio, et al.
Publicado: (2018)

The Role of Cytotoxic T-Lymphocyte Antigen 4 in the Pathogenesis of Multiple Sclerosis
por: Basile, Maria Sofia, et al.
Publicado: (2022)

Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma
por: Ferrucci, Pier Francesco, et al.
Publicado: (2021)

Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma
por: Comin-Anduix, Begoña, et al.
Publicado: (2008)

Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial
por: Johansson, Harriet, et al.
Publicado: (2021)

Melanoma antigens and antibodies
por: Embleton, M.J.
Publicado: (1983)

A matrix metalloproteinase inhibitor enhances anti-cytotoxic T lymphocyte antigen-4 antibody immunotherapy in breast cancer by reprogramming the tumor microenvironment
por: LI, MINGYUE, et al.
Publicado: (2016)

Antigen presentation to cytotoxic T lymphocytes in vivo
Publicado: (1995)

Cytotoxic T lymphocyte responses against melanocytes and melanoma
por: Chang, Gwendolen Y, et al.
Publicado: (2011)

Genetic Polymorphisms of Cytotoxic T-Lymphocyte Antigen 4 in Primary Biliary Cholangitis: A Meta-Analysis
por: Yang, Xing-Chen, et al.
Publicado: (2017)

Cytotoxic T lymphocyte antigen 4 polymorphism 49 (A→G) and migraine
por: Lulli, P., et al.
Publicado: (2005)

Cytotoxic T lymphocyte antigen-4 expression in esophageal carcinoma: implications for prognosis
por: Zhang, Xiao-Fei, et al.
Publicado: (2016)

Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis
por: Cho, Hyosun, et al.
Publicado: (2017)

Vitamin D and the Risk of Non-Melanoma Skin Cancer: A Systematic Literature Review and Meta-Analysis on Behalf of the Italian Melanoma Intergroup
por: Caini, Saverio, et al.
Publicado: (2021)

Antigen receptor-regulated exocytosis in cytotoxic T lymphocytes
Publicado: (1987)

Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Regulates the Unfolding of Autoimmune Diabetes
por: Lühder, Fred, et al.
Publicado: (1998)

Delivery of Exogenous Antigens to Induce Cytotoxic CD8+ T Lymphocyte Responses
por: Kim, Julia, et al.
Publicado: (2010)

Cytotoxic T lymphocyte antigen 4 expression in human breast cancer: implications for prognosis
por: Yu, Haiming, et al.
Publicado: (2015)

Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: Another Therapeutic Side of Capecitabine
por: Derakhshani, Afshin, et al.
Publicado: (2021)

Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma
Publicado: (1988)

Induction of Cytotoxic T Lymphocyte Antigen 4 (Ctla-4) Restricts Clonal Expansion of Helper T Cells
por: Doyle, Alden M., et al.
Publicado: (2001)

Successful treatment with avapritinib in patient with mucosal metastatic melanoma
por: Cocorocchio, Emilia, et al.
Publicado: (2020)

Acquisition of cytotoxic T lymphocyte-specific carbohydrate differentiation antigens
Publicado: (1985)

Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes
por: Feder-Mengus, C, et al.
Publicado: (2007)

Concanavalin A-mediated activation of antigen-primed lymphocytes into secondary cytotoxic lymphocytes
Publicado: (1977)

Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes
por: Rollinghoff, M, et al.
Publicado: (1977)

An Activating Janus Kinase-3 Mutation Is Associated with Cytotoxic T Lymphocyte Antigen-4-Dependent Immune Dysregulation Syndrome
por: Sic, Heiko, et al.
Publicado: (2017)

Modulation of Susceptibility to HIV-1 Infection by the Cytotoxic T Lymphocyte Antigen 4 Costimulatory Molecule
por: Riley, James L., et al.
Publicado: (2000)

Cytotoxic T-Lymphocyte Associated Antigen 4 Polymorphisms and Asthma Risk: A Meta-Analysis
por: Nie, Wei, et al.
Publicado: (2012)

Case Report: Durable complete response of metastatic hepatocellular carcinoma with asymptomatic hyperamylasemia to combined immunotherapy of anti-cytotoxic T lymphocyte-associated antigen 4 plus anti-programmed cell death-1 antibodies
por: Gao, Han, et al.
Publicado: (2023)

BLOCKING AND REDISTRIBUTION ("CAPPING") OF ANTIGEN RECEPTORS ON T AND B LYMPHOCYTES BY ANTI-IMMUNOGLOBULIN ANTIBODY
por: Roelants, Georges, et al.
Publicado: (1973)

Rigid-body Ligand Recognition Drives Cytotoxic T-lymphocyte Antigen 4 (CTLA-4) Receptor Triggering
por: Yu, Chao, et al.
Publicado: (2011)

Association of Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) and Thyroglobulin (TG) Genetic Variants with Autoimmune Hypothyroidism
por: Patel, Hinal, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_frspeqp37tr39t9hfibglfg1m5